Clinical datasets and cancer genomic datasets from the cBioPortal website were analysed, and the results showed that in cases with TTK, CDC25A, and ESPL1 amplification, EC patients had worse survival outcomes (Figure 8(c)). The gene discussed is CDC25A; the disease is cancer.